| Dr Rodney T Franklin, MD | |
|
7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 | |
| (806) 698-8088 | |
| (806) 698-8588 |
| Full Name | Dr Rodney T Franklin |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 39 Years |
| Location | 7008 Indiana Ave, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649384280 | NPI | - | NPPES |
| 139821621 | Medicaid | TX | |
| 112995105 | Other | TX | FIRST CARE |
| 8334M0 | Other | TX | BLUE CROSS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of West Texas Llc | Lubbock, TX | Home health agency |
| Accolade Home Care | Lubbock, TX | Home health agency |
| Hospice Of Lubbock Inc | Lubbock, TX | Hospice |
| Area Community Hospice Inc | Plainview, TX | Hospice |
| Interim Hospice Of West Texas | Lubbock, TX | Hospice |
| Covenant Medical Center | Lubbock, TX | Hospital |
| Lakeside Rehabilitation And Care Center | Lubbock, TX | Nursing home |
| Carillon Inc | Lubbock, TX | Nursing home |
| The Mildred & Shirley L Garrison Geriatric Educati | Lubbock, TX | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lfm Associates | 4082020086 | 10 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
| Entity Name | Rodney T Franklin Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346373289 PECOS PAC ID: 1658262191 Enrollment ID: O20040323001330 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
| Entity Name | Physicians Unity |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679878268 PECOS PAC ID: 6406014919 Enrollment ID: O20120229000568 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
| Entity Name | Lfm Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255925756 PECOS PAC ID: 4082020086 Enrollment ID: O20210316001849 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
| Entity Name | Tcvi Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225779390 PECOS PAC ID: 7517301732 Enrollment ID: O20240215003013 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rodney T Franklin, MD 7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 Ph: (806) 698-8088 | Dr Rodney T Franklin, MD 7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 Ph: (806) 698-8088 |
News Archive
To help develop a therapeutic treatment for citrus greening disease, a bacterial infection that threatens the future of the U.S. citrus industry, the United States Department of Agriculture Specialty Crop Research Initiative has awarded a diverse group of researchers a $10 million grant.
A new study summarized in a research letter published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy, health care experiences, and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
› Verified 4 days ago
Charles Hudson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Phone: 972-829-6613 Fax: 800-611-5029 | |
Dr. Ronald L. Cook, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 1c143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |